HSU ERIC C has filed 9 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 13000 shares of InMed Pharmaceuticals Inc. ($INM) on December 19, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 19, 2025 | InMed Pharmaceuticals Inc. | $INM | HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | A | Employee Stock Option (Right to Buy) | 13000 | $0.00 | 18,280.0000 | 3,954,549 | 246.21% | 0.33% |
| Dec. 15, 2025 | InMed Pharmaceuticals Inc. | $INM | HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | H | Employee Stock Option (Expiration) | 70 | $0.00 | 5,280.0000 | 3,954,549 | 1.31% | 0.00% |
| Dec. 20, 2024 | InMed Pharmaceuticals Inc. | $INM | HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | A | Employee Stock Option (Right to Buy) | 2750 | $0.00 | 5,350.0000 | 620,127 | 105.77% | 0.44% |
| May 27, 2024 | InMed Pharmaceuticals Inc. | $INM | HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | H | Employee Stock Option (Expiration) | 545 | $0.00 | 52,000.0000 | 480,649 | 1.04% | 0.11% |
| March 4, 2024 | InMed Pharmaceuticals Inc. | $INM | HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | H | Employee Stock Option (Expiration) | 309 | $0.00 | 52,545.0000 | 398,673 | 0.58% | 0.08% |
| Dec. 23, 2023 | InMed Pharmaceuticals Inc. | $INM | HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | A | Employee Stock Option (Right to Buy) | 45000 | $0.00 | 52,854.0000 | 166,410 | 572.96% | 27.04% |
| Aug. 31, 2023 | InMed Pharmaceuticals Inc. | $INM | HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | H | Employee Stock Option (Expiration) | 327 | $0.00 | 7,854.0000 | 2,448,458 | 4.00% | 0.01% |
| May 16, 2023 | InMed Pharmaceuticals Inc. | $INM | HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | H | Employee Stock Option (Expiration) | 152 | $0.00 | 8,181.0000 | 3,328,191 | 1.82% | 0.00% |
| March 8, 2023 | InMed Pharmaceuticals Inc. | $INM | HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | H | Employee Stock Option (Expiration) | 545 | $0.00 | 8,333.0000 | 2,300,526 | 6.14% | 0.02% |